Max pain, also called the maximum pain price, is the options strike price at which the highest combined dollar value of call and put contracts will expire worthless. It is the price point where option buyers collectively lose the most money upon expiration. The theory behind max pain suggests that stock prices tend to gravitate toward this level as expiration approaches, which benefits option sellers, primarily market makers, who collect the most premium when contracts expire out-of-the-money.
The HFRI Event Driven Merger Arbitrage Index and various derivatives analytics platforms update max pain calculations daily using open interest data released each morning by the Options Clearing Corporation.
The calculation is mechanical and requires only publicly available options data.
For example, if a stock is trading at $102 and has large open interest concentrations at the $100 and $105 strikes, the max pain price might settle around $101. Enough buyers at $100 calls expire in-the-money by only $1, and most $105 call buyers expire worthless entirely.
Market makers are typically net sellers of options contracts. Because they sell both calls and puts, they have a financial incentive for as many contracts as possible to expire worthless. To hedge their options positions and maintain delta neutrality, market makers buy and sell the underlying stock as the expiration date approaches. This hedging activity can create price pressure toward the max pain level, particularly in stocks with high options open interest relative to average daily trading volume.
This is not market manipulation in the traditional sense. It is a structural consequence of how market makers manage risk. The result, nonetheless, can look like a magnetic pull toward a specific strike price during expiration week.
A 25-year study of U.S. stock and options data from 1996 to 2021, titled "No Max Pain, No Max Gain," found that the theory holds meaningful predictive weight for smaller-cap, less-liquid stocks. The strategy of buying high-max-pain stocks and shorting low-max-pain stocks generated a consistent average weekly return of 0.4% in the study. For large-cap stocks and index options like those on the SPDR S&P 500 ETF, max pain has little predictive power because market forces are too broad to be influenced by any single hedging dynamic.
Max pain is most relevant during the week immediately preceding monthly options expiration. The directional effects, if they exist, tend to manifest in the final four to five trading days of each contract cycle.
Traders incorporate max pain in several practical ways, always as a supplemental signal rather than a standalone system.
Max pain is a theory, not a law. Macro events, earnings reports, analyst upgrades, or geopolitical developments can override any gravitational pull toward the max pain level. The calculation also shifts daily as traders open and close positions, so the max pain level from Monday may be meaningless by Thursday. Some market participants argue that the theory invites assumptions of intentional price manipulation that are difficult to prove and legally questionable.